Literature DB >> 3307572

Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study.

L Gattinoni, A Pesenti, L Avalli, F Rossi, M Bombino.   

Abstract

To investigate the relationship between lung anatomy and pulmonary mechanics in acute respiratory failure (ARF), 20 patients with ARF underwent computerized tomography (CT) at 3 levels of positive end-expiratory pressure (PEEP) (5, 10, and 15 cm H2O). The static pressure-volume curve of the total respiratory system and the lung volumes (helium dilution method) were also measured. By knowing the lung volumes and analyzing the CT number frequency distribution, a quantitative estimate of normally aerated, poorly aerated, and nonaerated lung tissue was obtained at each level of PEEP. The recruitment was defined as the percent increase of normally aerated tissue from 5 to 15 cm H2O. We found that the different compliances (starting compliance, inflation compliance, and deflation compliance) were correlated only with the amount of normally aerated tissue present in the range of pressures explored by a given compliance (5 cm H2O for starting compliance and 15 cm H2O for inflation and deflation compliances). No relationship was found between the compliances and the poorly aerated and nonaerated tissue. The specific compliance was in the normal range, whereas the amount of recruitment was related to the ratio of inflation compliance to starting compliance. Our data suggest that (1) the pressure-volume curve parameters in ARF investigate only the residual healthy zones of the lung and do not directly estimate the "amount" of disease (poorly or nonaerated tissue), (2) the pressure-volume curve may allow an estimate of the anatomic recruitment, and (3) the residual normally aerated zones of the ARF lung seem to maintain a normal intrinsic elasticity.

Entities:  

Mesh:

Year:  1987        PMID: 3307572     DOI: 10.1164/ajrccm/136.3.730

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  134 in total

Review 1.  Non-invasive imaging of regional lung function using x-ray computed tomography.

Authors:  B A Simon
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  The pulmonary physician in critical care * 7: ventilator induced lung injury.

Authors:  T Whitehead; A S Slutsky
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

3.  Early patterns of static pressure-volume loops in ARDS and their relations with PEEP-induced recruitment.

Authors:  Antoine Vieillard-Baron; Sebastien Prin; Karim Chergui; Bernard Page; Alain Beauchet; François Jardin
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

Review 4.  The pulmonary physician in critical care. 8: Ventilatory management of ALI/ARDS.

Authors:  J J Cordingley; B F Keogh
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

5.  PEEP, ARDS, and alveolar recruitment.

Authors:  J Mancebo
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 6.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

7.  Target blood gases during ARDS ventilatory management.

Authors:  A Pesenti
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

8.  Point: should positive end-expiratory pressure in patients with ARDS be set on oxygenation? Yes.

Authors:  Russell R Miller; Neil R MacIntyre; R Duncan Hite; Jonathon D Truwit; Roy G Brower; Alan H Morris
Journal:  Chest       Date:  2012-06       Impact factor: 9.410

9.  Quantitative CT in ARDS: towards a clinical tool?

Authors:  Luciano Gattinoni; Massimo Cressoni
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

10.  [Protective ventilation in the operating room: absence of evidence is not evidence of absence].

Authors:  M Gama de Abreu; A Güldner; T Koch
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.